Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein Occlusion
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein Occlusion
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Volume 22, Issue 6, Pages 1013-1018
Publisher
SAGE Publications
Online
2012-05-06
DOI
10.5301/ejo.5000162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aqueous Humor Levels of Vasoactive Molecules Correlate with Vitreous Levels and Macular Edema in Central Retinal Vein Occlusion
- (2018) Hidetaka Noma et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Bevacizumab in Central Retinal Vein Occlusion: A Retrospective Analysis after 2 Years of Treatment
- (2018) Andreas Stahl et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion: Perfused vs. Ischemic and Early vs. Late Treatment
- (2012) Francis Char DeCroos et al. CURRENT EYE RESEARCH
- Intravitreal Bevacizumab in Central Retinal Vein Occlusion: 18-month Results of a Prospective Clinical Trial
- (2011) Peep V. Algvere et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Efficacy of Ranibizumab in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion: Results From the Sham-Controlled ROCC Study
- (2010) Bettina Kinge et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Results of bevacizumab as the primary treatment for retinal vein occlusions
- (2010) M. S. Figueroa et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion
- (2010) Alexandra Eva Hoeh et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Bevacizumab (Avastin) in the Treatment of Macular Edema Associated With Perfused Retinal Vein Occlusion
- (2010) Kuo-Hsuan Hung et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
- (2010) David M. Brown et al. OPHTHALMOLOGY
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
- (2009) ARCHIVES OF OPHTHALMOLOGY
- Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion
- (2009) Thomas Ach et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Ischaemic change after intravitreal bevacizumab (Avastin®) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion
- (2008) Kwan Soo Kim et al. ACTA OPHTHALMOLOGICA
- Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion
- (2008) Florian Rensch et al. ACTA OPHTHALMOLOGICA
- Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion
- (2008) Richard F. Spaide et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions
- (2008) Dante J. Pieramici et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started